Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Inflammatory Bowel Disease, Pancreatitis Pathology and Treatment, and Microscopic Colitis.
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Clinical Cancer Research2013cited by 165position: middledoi